Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
$5.44
-0.4500 ( -7.64% ) 647.3K
BiondVax Pharmaceuticals Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline.
Market Data
Open
$5.44
Previous close
$5.89
Volume
647.3K
Market cap
$4.45M
Day range
$4.95 - $5.80
52 week range
$2.23 - $13.70
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Sep 06, 2023 |
6-k | Quarterly Reports | 30 | Sep 06, 2023 |
6-k | Quarterly Reports | 1 | Aug 24, 2023 |
6-k | Quarterly Reports | 23 | Aug 23, 2023 |
6-k/a | Quarterly Reports | 35 | Aug 18, 2023 |
6-k/a | Quarterly Reports | 37 | Aug 14, 2023 |
6-k | Quarterly Reports | 3 | Aug 11, 2023 |
6-k | Quarterly Reports | 2 | Aug 01, 2023 |
6-k | Quarterly Reports | 5 | Jul 12, 2023 |
6-k | Quarterly Reports | 30 | Jul 05, 2023 |